Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
disease | 0.120 | None | 1.000 | 3 | 13 | 1976 | 2011 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.200 | None | 1.000 | 2 | 2 | 1981 | 2014 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.200 | None | 1.000 | 3 | 43 | 1982 | 2018 | ||||||||
|
complement factor B | 0.532 | 0.769 | 4.7E-16 |
|
disease | 0.140 | None | 0.857 | 3 | 7 | 1985 | 2015 | ||||||||
|
major histocompatibility complex, class II, DO alpha | 0.509 | 0.808 | 3.0E-10 |
|
disease | 0.140 | None | 1.000 | 3 | 10 | 1986 | 2016 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.500 | None | 0.938 | 3 | 62 | 1988 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.936 | 6 | 4 | 1989 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.700 | None | 0.975 | 1 | 2 | 1989 | 2020 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.200 | None | 0.962 | 4 | 7 | 1990 | 2016 | ||||||||
|
major histocompatibility complex, class II, DP alpha 1 | 0.552 | 0.846 | 2.5E-06 |
|
disease | 0.140 | None | 0.857 | 3 | 8 | 1990 | 2017 | ||||||||
|
ribonuclease P/MRP subunit p14 | 0.544 | 0.808 | 1.9E-03 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 1990 | 2019 | ||||||||
|
protein tyrosine phosphatase receptor type C | 0.435 | 0.808 | 1.00 |
|
disease | 0.480 | None | 1.000 | 1 | 1 | 1991 | 2017 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.500 | None | 1.000 | 4 | 2 | 1992 | 2019 | ||||||||
|
interleukin 2 receptor subunit beta | 0.491 | 0.846 | 0.29 |
|
disease | 0.470 | None | 0.909 | 2 | 3 | 1992 | 2019 | ||||||||
|
interferon stimulated exonuclease gene 20 | 0.414 | 0.846 | 2.9E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 1992 | 2018 | ||||||||
|
major histocompatibility complex, class I, C | 0.415 | 0.846 | 1.6E-06 |
|
disease | 0.200 | None | 0.944 | 1 | 14 | 1993 | 2019 | ||||||||
|
transporter 2, ATP binding cassette subfamily B member | 0.517 | 0.808 | 6.9E-11 |
|
disease | 0.200 | None | 1.000 | 3 | 4 | 1994 | 2016 | ||||||||
|
CD28 molecule | 0.436 | 0.885 | 0.36 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 1996 | 2018 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.200 | None | 1.000 | 3 | 4 | 1997 | 2017 | ||||||||
|
major histocompatibility complex, class II, DM beta | 0.638 | 0.615 | 2.5E-03 |
|
disease | 0.180 | None | 0.800 | 2 | 5 | 1997 | 2009 | ||||||||
|
negative elongation factor complex member E | 0.686 | 0.500 | 6.9E-03 |
|
disease | 0.120 | None | 0.667 | 1 | 8 | 1997 | 2011 | ||||||||
|
proline rich coiled-coil 2A | 0.656 | 0.654 | 1.00 |
|
disease | 0.130 | None | 1.000 | 3 | 15 | 1998 | 2011 | ||||||||
|
proteasome 20S subunit beta 8 | 0.533 | 0.808 | 2.2E-02 |
|
disease | 0.110 | None | 1.000 | 2 | 4 | 1998 | 2009 | ||||||||
|
proteasome 20S subunit beta 9 | 0.514 | 0.808 | 2.7E-03 |
|
disease | 0.110 | None | 1.000 | 1 | 3 | 1998 | 2009 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.500 | None | 0.889 | 5 | 5 | 2000 | 2019 |